TRADE NEWS: Agilent Technologies Inc. Tools Used to Derive New Type of Mouse Embryonic Stem Cell that Shares Key Features of Human Embryonic Stem Cells

SANTA CLARA, Calif.--(BUSINESS WIRE)--Using a variety of Agilent Technologies (NYSE:A) genomics tools, researchers at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and the University of Oxford, U.K., have achieved a major milestone in solving some of the perplexing differences between embryonic stem (ES) cells of humans and mice, according to a paper published in the current issue of Nature (Vol. 448 No. 7150).

MORE ON THIS TOPIC